arrow
H

Hiroyuki Sakai

kanagawa physicians association
H指数:21
被引数:1,950

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of sacubitril/valsartan according to daily salt intake and comparison with thiazide add-on treatment in patients with uncontrolled hypertension

根据每日盐摄入量的沙库必利/缬沙坦的效果及与噻嗪类利尿剂加用治疗在未控制高血压患者中的比较

2025-11-140
PRE
Comparison of renal effects between sacubitril/valsartan and thiazide diuretics among patients with uncontrolled hypertension and chronic kidney disease in Japan

在日本未控制高血压合并慢性肾脏病患者中,沙库巴曲/缬沙坦与噻嗪类利尿剂的肾效应比较

2025-09-010
PRE
Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan

日本糖尿病患者中血压控制不佳者使用沙库巴曲/缬沙坦影响作用的回顾性分析

2025-07-180
OAAI
Comparison between sacubitril/valsartan and thiazide diuretics among patients with uncontrolled hypertension in Japan

在日本未控制高血压患者中,沙库巴曲/缬沙坦与噻嗪类利尿剂的比较

2025-05-190
PRE
Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine
2023-06-212
PRE
Comparison of renal outcomes between sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists

钠-葡萄糖共转运蛋白2抑制剂与胰高血糖素样肽1受体激动剂对肾脏预后的比较

2022-03-018
PRE
Retrospective Analysis of the Renoprotective Effects of Long-Term Use of Six Types of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
2021-02-0111
PREAI
Blood pressure after treatment with sodium-glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score-matched models
2020-07-107
OAAI
Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease
2019-11-037
OAAI
HLA-DQ and RBFOX1 as susceptibility genes for an outbreak of hydrolyzed wheat allergy
2019-11-0123
OAAI